These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24261744)

  • 1. 'Drugs from bugs': bacterial effector proteins as promising biological (immune-) therapeutics.
    Rüter C; Hardwidge PR
    FEMS Microbiol Lett; 2014 Feb; 351(2):126-32. PubMed ID: 24261744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural product derived immune-regulatory agents.
    Talmadge JE
    Int Immunopharmacol; 2016 Aug; 37():5-15. PubMed ID: 26968760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological Disorders.
    Mu Y; McManus DP; Hou N; Cai P
    Front Immunol; 2021; 12():619776. PubMed ID: 33692793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunomodulatory and anti-inflammatory properties of different antimicrobial agents].
    Guz K; Bugla-Płoskońska G
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():828-37. PubMed ID: 18097341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.
    Mahlapuu M; Håkansson J; Ringstad L; Björn C
    Front Cell Infect Microbiol; 2016; 6():194. PubMed ID: 28083516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage Cytological Profiling and Anti-Inflammatory Drug Discovery.
    Lau TA; Bray WM; Lokey RS
    Assay Drug Dev Technol; 2019 Jan; 17(1):14-16. PubMed ID: 30657701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant Natural Products Targeting Bacterial Virulence Factors.
    Silva LN; Zimmer KR; Macedo AJ; Trentin DS
    Chem Rev; 2016 Aug; 116(16):9162-236. PubMed ID: 27437994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens.
    Finlay BB; McFadden G
    Cell; 2006 Feb; 124(4):767-82. PubMed ID: 16497587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSK3β and the control of infectious bacterial diseases.
    Wang H; Kumar A; Lamont RJ; Scott DA
    Trends Microbiol; 2014 Apr; 22(4):208-17. PubMed ID: 24618402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Penetrating Bacterial Effector Proteins: Better Tools than Targets.
    Rüter C; Schmidt MA
    Trends Biotechnol; 2017 Feb; 35(2):109-120. PubMed ID: 27592802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulators as an antimicrobial tool.
    Pirofski LA; Casadevall A
    Curr Opin Microbiol; 2006 Oct; 9(5):489-95. PubMed ID: 16931122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Effector-Mediated Immunity Revealed by the Accidental Human Pathogen
    Ngwaga T; Chauhan D; Shames SR
    Front Cell Infect Microbiol; 2020; 10():593823. PubMed ID: 33614523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
    Pérez Del Palacio J; Díaz C; de la Cruz M; Annang F; Martín J; Pérez-Victoria I; González-Menéndez V; de Pedro N; Tormo JR; Algieri F; Rodriguez-Nogales A; Rodríguez-Cabezas ME; Reyes F; Genilloud O; Vicente F; Gálvez J
    J Biomol Screen; 2016 Jul; 21(6):567-78. PubMed ID: 26962874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.
    Igietseme JU; Eko FO; He Q; Black CM
    Expert Rev Vaccines; 2004 Feb; 3(1):23-34. PubMed ID: 14761241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deriving Immune-Modulating Peptides from Viral Serine Protease Inhibitors (Serpins).
    Yaron JR; Zhang L; Burgin M; Schutz LN; Awo EA; Keinan S; McFadden G; Ambadapadi S; Guo Q; Chen H; Lucas AR
    Methods Mol Biol; 2021; 2225():107-123. PubMed ID: 33108660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial degradation of immunoglobulin A1 in relation to periodontal diseases.
    Grønbaek Frandsen EV
    APMIS Suppl; 1999; 87():1-54. PubMed ID: 10189832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutic approaches by using microorganism-derived compounds.
    Amedei A; D'Elios MM
    Curr Med Chem; 2012; 19(22):3822-40. PubMed ID: 22489726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of molecular mimicry candidates in human pathogenic bacteria.
    Doxey AC; McConkey BJ
    Virulence; 2013 Aug; 4(6):453-66. PubMed ID: 23715053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies.
    Thakur A; Mikkelsen H; Jungersen G
    J Immunol Res; 2019; 2019():1356540. PubMed ID: 31111075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging insights into bacterial deubiquitinases.
    Kubori T; Kitao T; Nagai H
    Curr Opin Microbiol; 2019 Feb; 47():14-19. PubMed ID: 30391778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.